Monometacrine
Clinical data | |
---|---|
Other names | Desmethyldimetacrine; Nordimetacrine; N-Desmethyldimetacrine; SD-735; NSC-100296 |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C19H24N2 |
Molar mass | 280.415 g·mol−1 |
3D model (JSmol) | |
| |
|
Monometacrine (INN ; developmental code name SD-735), also known as desmethyldimetacrine, is a drug of the tricyclic family described as an antidepressant which was never marketed.[1][2][3] It was first described in the literature by 1966.[1] The drug is the N-desmethyl analogue of dimetacrine and is a metabolite of dimetacrine.[1][3]
References
- ^ a b c Elks J (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 835. ISBN 978-1-4757-2085-3. Retrieved 20 October 2024.
- ^ Negwer M, Scharnow HG (2001). Organic-chemical Drugs and Their Synonyms: An International Survey. Wiley-VCH. p. 1788. ISBN 978-3-527-30247-5. Retrieved 20 October 2024.
- ^ a b "Monometacrine". Inxight Drugs. National Center for Advancing Translational Sciences (NCATS). Retrieved 20 October 2024.
See what we do next...
OR
By submitting your email or phone number, you're giving mschf permission to send you email and/or recurring marketing texts. Data rates may apply. Text stop to cancel, help for help.
Success: You're subscribed now !